All good legendary, I suppose I'm being on the conservative side. I'm not wanting to get myself expecting a re-rate on the Scoping Study release to be disappointed. We are in a tough IO environment, and there's every chance the market is already expecting an OPEX of $50 and a small CAPEX, so confirmation of this may not move the needle too much. There might be a small movement upwards, but not expecting anything large. I definitely agree that any real re-rating will occur after CAPEX finance sorted, however that may end up being achieved.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.71M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 15.0¢ | 14.0¢ | $19.29K | 130.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 14.40pm 20/06/2025 (20 minute delay) ? |
| EQX (ASX) Chart |